Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria (Q38875514)

7 September 2017

title

Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria (English)

1 reference

tropical endomyocardial fibrosis

7 September 2017

0 references

1 reference

Andy JJ

1 reference

7 September 2017

Ogunowo PO

1 reference

7 September 2017

Akpan NA

1 reference

7 September 2017

Odigwe CO

1 reference

7 September 2017

Ekanem IA

1 reference

7 September 2017

Esin RA

1 reference

7 September 2017

language of work or name

1 reference

1 May 1998

1 reference

7 September 2017

1 reference

7 September 2017

1 reference

7 September 2017

1 reference

7 September 2017

page(s)

127-140

1 reference

Value of two-dimensional echocardiography in endomyocardial disease with and without eosinophilia. A clinical and pathologic study

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900125-3

Trichinosis causing extensive ventricular mural endocarditis with superimposed thrombosis. Evidence that severe eosinophilia damages endocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900125-3

Relation of severe eosinophilia and microfilariasis to chronic African endomyocardial fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900125-3

Restrictive cardiomyopathy associated with the eosinophilia-myalgia syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900125-3

Endomyocardial fibrosis in Europeans resident in tropical Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900125-3

Endomyocardial fibrosis in Uganda (Davies' disease). 1. An epidemiologic, clinical, and pathologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900125-3

Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900125-3

Epidemiology aspects of endomyocardial fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900125-3

Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900125-3

Relation between eosinophilia and endomyocardial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900125-3

The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900125-3

Endomyocardial fibrosis and eosinophilia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900125-3

Endomyocardial fibrosis in Egypt: an illustrated review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900125-3

Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900125-3

Immunohistological and serological studies in endomyocardial fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2897%2900125-3

10.1016/S0001-706X(97)00125-3

7 January 2021

Identifiers

DOI

1 reference

7 September 2017

1 reference